EGFR and Parkinson disease: Notably, PINK1-PRKN MEDIATED MITOPHAGY, UREA CYCLE, DEGRADATION OF CYSTEINE AND HOMOCYSTEINE, MITOPHAGY and SIGNALING BY EGFR IN CANCER were enriched in PD, suggesting mitochondrial dysfunction and metabolic abnormalities (Figure 2L).